In the United States, we are largely sheltered from some diseases which have a great disease burden globally. Tuberculosis (TB) is one such disease, accounting for nine million newly diagnosed cases and two million deaths annually.
Research and breakthroughs at the intersection of biology and medicine — from gene editing and synthetic biology to clinical trials, diagnostics, and the science driving next-generation therapies.
